18,000 people scheduled, on average, per hour

The National Steering Committee for Covid-19 Vaccination (CNCAV) announced on Saturday that by 2 p.m., nearly 110,000 people had been scheduled on the platform for immunization with the Pfizer BioNTech vaccine.

“Marathon for registrations on the vaccination platform! Over 18,000 people are scheduled, on average, per hour! 302 people / minute scheduled until 14:00 “, announced CNCAV.

According to Committee representatives, 109,800 people have been scheduled on the platform programare.vaccinare-covid.gov.ro to be vaccinated in the new open cabinets for the administration of the serum produced by Pfizer-BioNTech.

CNCAV announced that from Saturday, vulnerable people can be scheduled for immunization with the Pfizer / BioNTech vaccine in the 130 new offices opened for this purpose. 156,000 people will be able to be vaccinated in the next 20 days in these offices. The vaccination capacity of each office is 60 people per day, CNCAV representatives announced.

These are people who are part of Stage II of the vaccination strategy, namely people with chronic diseases, over 65 years of age and people with disabilities.

Also, in parallel, the programming of the persons enrolled in the immunization process with the vaccine produced by the Oxford / AstraZeneca company continues.

890,068 people have been immunized in Romania since the start of the vaccination campaign on December 27, 2020, according to the National Committee for the Coordination of Activities on Vaccination against Covid-19 (CNCAV).

So far, 799,164 cases of COVID-19 have been reported in Romania, of which 738,569 have been declared cured. The latest COVID-19 balance sheet, sent by the Strategic Communication Group (GCS), can be consulted on Mediafax.ro.

For the most important news of the day, broadcast in real time and presented equidistantly, LIKE our Facebook page!

Follows Mediafax on Instagram to see spectacular images and stories from around the world!

The content of the website www.mediafax.ro is intended exclusively for your personal information and use. It is prohibited republishing the content of this site in the absence of an agreement from MEDIAFAX. To obtain this agreement, please contact us at [email protected]

Source: Mediafax by www.mediafax.ro.

*The article has been translated based on the content of Mediafax by www.mediafax.ro. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!